Independent Review Committee

in page functions

Gavi has established an Independent Review Committee for the review of new proposals

To support an independent and systematic process of reviewing new proposals, Gavi has established an Independent Review Committee (IRC).

Key characteristics

Since its inception, the structure and composition of the Gavi IRC have been considered effective due to key characteristics:

  • the committee relies upon a wide range of experts in public health, epidemiology, development, finance and economics;
  • the committee is based on a system of peer review; and
  • the committee is independent.

The Gavi Board

The IRC is directly accountable to the Gavi Board and communicates its recommendations to the Gavi Board. The Gavi Board makes the ultimate decision on whether to approve the funding of new country grants. The Gavi Board also has the responsibility for communicating its decision to countries, via the Gavi Secretariat.

The Independent Review Committee reviews new proposals and makes recommendations to the Gavi Board

The mandate of the new proposals IRC is to review each application for all types of new support, to enable a more holistic view of the broad portfolio of support Gavi provides to countries, rather than looking at each new application in isolation from the others, and to make recommendations to the Gavi Board.

This review should consider the information available to countries within current guidelines and application forms and ensure that any new proposal contributes to achieving:

  • the Gavi mission - ‘To save children’s lives and protect people’s health by increasing access to immunisation in poor countries’;
  • the Gavi's strategic goals; and
  • the eligibility criteria as per Gavi guidelines for new proposals of support.

Members of the Independent Review Committee consist of specialists from a broad range of expertise

IRC members generally serve a term of three years. This term may be renewed for another period of up to 3 years. Upon reaching the second term limit IRC members will not be eligible to serve on the IRC for at least 1 year. During their term IRC members may be called upon to serve on the IRC for review of country plans or requests for extensions for which he or she has specific relevant skills.

Click here to view Terms of Reference for the Gavi Independent Review Committee  

Range of expertise

The increasing complexity of new proposals and the subsequent grant monitoring requires an IRC with a broad range of expertise in areas such as:

  • Routine immunisation programmes, especially at country level;
  • Management of campaigns;
  • Delivery of health services including child and adolescent health;
  • Health systems strengthening and management;
  • Epidemiology and disease control;
  • Cold chain and logistics;
  • Financial and budget analysis; and
  • Gender and equity.

The IRC should also consist of technical experts knowledgeable on the developing country context and relevant issues, including in a variety of fields related to immunisation and health systems, and who have practical experience working in or with developing country governments, civil society, and other partners in those contexts. In addition, the IRC should be geographically diverse, with a male and female representation consistent with Gavi’s Gender Policy and Guidelines on the Gavi Board Gender Balance.

Each IRC member is asked to sign a confidentiality and conflict of interest statement and will not come from Vaccine Alliance partner agencies, and have not taken part in technical assistance to or pre-review processes of country applications.

List of IRC pool members

Click here to view the biographies of the IRC members  

Nr

Name

Areas of expertise

Current position

1

Emmanuel Addo-Yobo

Child health; clinical paediatrics; surveillance for rotavirus and congenital rubella syndrome

Professor of Child Health at the School of Medical Sciences, College of Health Sciences, Kwame Nkrumah University of Science and Technology, Ghana

2

Salah Al Awaidy

Vaccine-preventable diseases programming, immunisation and cold chain

Advisor at the Ministry of Health, Oman

3

Rafah Salam Aziz

MNCH programme management, immunisation

Independent consultant

4

Alejo Bejemino

Cold Chain/Supply Chain and Logistics Management

Independent consultant

5

Annette Bongiovanni

Programme management, monitoring and evaluation, and operations research

Principal at International and Business Technical Consultants, Inc, United States

6

Aleksandra Caric

Immunization – vaccine safety and regulation, programme management and administration

Independent consultant, Medical doctor - GP

7

Gabriel Carrasquilla

Epidemiology

Founder and Director of ASIESALUD

8

Amos Chweya

Public health logistics, procurement and logistics management of immunization activities

Regional Immunization Logistics Technical Officer with JSI, Kenya

9

John Clements

Routine immunisation services in developing countries

Independent consultant and Associate Professor in the School of Population Health, Faculty of Medicine and Dentistry, University of Melbourne

10

Dora Curry

CSOs, data systems at community and primary care level, data utilization for program improvement

Senior Technical Advisor for Monitoring and Evaluation in CARE-USA’s Sexual, Reproductive and Maternal Health team

11

Ranjit Dhiman

Cold chain logistics, Immunization supply chain,

Independent consultant

12

Modibo Dicko

Supply chain management, introducing innovative technologies, management systems and practices in health supply systems

Director of the “Informed Push Model” Project at Office of Intrahealth International, Senegal

13

Abdoulaye Oumar Djigo

Management, Logistics in Health Sector, Engineering (Cold chain, biomedical equipment, energy efficiency, environment),

Independent consultant

14

Linda Eckert

Vaccines, especially in the intersection of immunisation with reproductive health

Professor in Obstetrics and Gynecology and Adjunct Professor in the Department of Global Health at the University of Washington in Seattle

15

Ulla Kou Griffiths

Economics of vaccines, economic evaluations of new vaccines

Lecturer in Health Economics in the Department of Global Health and Development at the London School of Hygiene and Tropical Medicine (LSHTM)

16

Terence Hart

Supply chain logistics and technologies

Independent consultant

17

Philippe Jaillard

Vaccine delivery, cold chain equipment management, injection safety and waste management, logistics training program development

Program Director: Technologies and Health Logistics, project coordinator of LOGIVAC

18

Shaikh Humayun Kabir

Vaccine management, assessment and review of country cold chain and logistics, Vaccine preventable disease epidemiology

Independent consultant

19

Miloud Kaddar

Health economics, economics of vaccines and immunization, health system development and financing

Independent consultant

20

Kabelwa Kagaruki

General public health, immunization logistics/supply chain, EPI monitoring and evaluation

Regional Immunization Technical Officer, JSI, Tanzania

21

Marina Madeo

Health systems strengthening, technical coordination, health sector governance

Independent consultant

22

Kapil Maithal

Conceptualizing, managing, strategizing and execution of development of vaccines for global use; vaccine advocacy and preparedness

General Manager and Head-Research and Development at Indian Immunologicals Limited (IIL), Hyderabad, India

23

Marty Makinen

Health economics, immunisation

Principal and Managing Director of Results for Development Institute (R4D) in Washington, DC

24

Osman Mansoor

Immunization programmes, pandemic planning & outbreak control, cold chain & logistics

Public health physician and independent consultant

25

Claude Mangobo

Management of cold chain equipment and vaccine management; maintenance and installation of solar cold chain equipment.

Regional Advisor for Immunization Logistics and Supply Chain at AMP, Regional Office for Africa

26

Sandra Mounier-Jack

Health policy and health financing

Lecturer in Health Policy at the Faculty of Public Health and Policy of the London School of Hygiene and Tropical Medicine

27

Amani Mustafa

Immunisation, new vaccines, campaign management, cold chain and health system planning and monitoring.

Public Health Training Initiative Project Manager, The Carter Center, Sudan. National Director of Planning, Monitoring, and Policy Directorate, National Medicines and Poisons Board, Sudan

28

Maryanne Neill

Health information systems, cold chain logistics, immunisation coverage estimation.

Independent consultant

29

Benjamin Nkowane

Vaccine preventable disease programme development, implementation of mass vaccination campaigns, technical support for field operations in security risk areas.

Independent Medical Epidemiologist and public health consultant

30

Frank Nyonator

Health systems and health service provision

Ag. Dean of the School of Public Health, University of Health and Allied Sciences (UHAS) Ghana, Head of the Health Policy, Planning and Management Department of the School

31

Adepeju Olukoya

Gender, women and health; sexual and reproductive health; health systems

Independent consultant

32

Bolanle Oyeledun

Health systems strengthening, MNCH, immunisation

Chief Executive Officer at Centre for Integrated Health Programs (CIHP), Nigeria

33

Koyejo Oyerinde

Paediatrics, Health Systems Strengthening

Attending paediatrician in private practice

34

Zeenat Patel

Public health, epidemiology, immunisation

Independent consultant

35

Arletty Pinel

Health systems strengthening, maternal health

Independent consultant

36

Robert (Bob) Pond

health systems strengthening with special emphasis on child health, disease control and HIS development

Independent consultant

37

Kshem Prasad

Evaluation of programme logistics, assessments of immunization supply chain and development of plans for system strengthening

Independent consultant

38

Bhimsen Raut

Cold chain and logistics, vaccine management

Independent consultant

39

Diana Rivington

Gender equality, human rights, children’s rights

Senior Fellow in the Faculty of Social Sciences at the University of Ottawa, Canada

40

Mario Stassen

Design of development strategies, risk management and patient safety

Lecturer at Faculty of Science, Department of Biopharmacy at University of Utrecht; Board member of the Edufarma Foundation

41

Ousmane Amadou Sy

Financial management systems for health

Independent consultant

42

Michael Thiede

Health economics, health policy and health systems, procurement and logistics

Managing Director of the Scenarium Group GmbH

43

Beena Varghese

Costing and evaluation of MNCH interventions; analysis of health system level issues in MNCH

Senior Health Economist at the Public Health Foundation of India (PHFI) and Adjunct Professor at the St. Johns Research Institute in Bangalore

44

Abdul G. Wali

Policy and strategy development, health information management, assessments, health system strengthening, immunization

Director of a leading Afghan NGO involved in research, monitoring and evaluation

45

Charles Shey Umaru Wiysonge

Vaccinology, systematic reviews, programme management

Full Professor and Deputy Director in the Centre for Evidence-based Health Care, Stellenbosch University, South Africa

46

Shamsa Zafar

MNCH, Gender

Head of Department, Centre of Excellence in MNCH at the Health Services Academy, Pakistan

close icon

modal window here